Carl Zeiss Meditec AG
XETRA:AFX

Watchlist Manager
Carl Zeiss Meditec AG Logo
Carl Zeiss Meditec AG
XETRA:AFX
Watchlist
Price: 55.45 EUR 1.46% Market Closed
Market Cap: 5B EUR
Have any thoughts about
Carl Zeiss Meditec AG?
Write Note

Intrinsic Value

The intrinsic value of one AFX stock under the Base Case scenario is 100.24 EUR. Compared to the current market price of 55.45 EUR, Carl Zeiss Meditec AG is Undervalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AFX Intrinsic Value
100.24 EUR
Undervaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Carl Zeiss Meditec AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for AFX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about AFX?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Carl Zeiss Meditec AG

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Carl Zeiss Meditec AG

Provide an overview of the primary business activities
of Carl Zeiss Meditec AG.

What unique competitive advantages
does Carl Zeiss Meditec AG hold over its rivals?

What risks and challenges
does Carl Zeiss Meditec AG face in the near future?

Summarize the latest earnings call
of Carl Zeiss Meditec AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Carl Zeiss Meditec AG.

Provide P/S
for Carl Zeiss Meditec AG.

Provide P/E
for Carl Zeiss Meditec AG.

Provide P/OCF
for Carl Zeiss Meditec AG.

Provide P/FCFE
for Carl Zeiss Meditec AG.

Provide P/B
for Carl Zeiss Meditec AG.

Provide EV/S
for Carl Zeiss Meditec AG.

Provide EV/GP
for Carl Zeiss Meditec AG.

Provide EV/EBITDA
for Carl Zeiss Meditec AG.

Provide EV/EBIT
for Carl Zeiss Meditec AG.

Provide EV/OCF
for Carl Zeiss Meditec AG.

Provide EV/FCFF
for Carl Zeiss Meditec AG.

Provide EV/IC
for Carl Zeiss Meditec AG.

Show me price targets
for Carl Zeiss Meditec AG made by professional analysts.

What are the Revenue projections
for Carl Zeiss Meditec AG?

How accurate were the past Revenue estimates
for Carl Zeiss Meditec AG?

What are the Net Income projections
for Carl Zeiss Meditec AG?

How accurate were the past Net Income estimates
for Carl Zeiss Meditec AG?

What are the EPS projections
for Carl Zeiss Meditec AG?

How accurate were the past EPS estimates
for Carl Zeiss Meditec AG?

What are the EBIT projections
for Carl Zeiss Meditec AG?

How accurate were the past EBIT estimates
for Carl Zeiss Meditec AG?

Compare the revenue forecasts
for Carl Zeiss Meditec AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Carl Zeiss Meditec AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Carl Zeiss Meditec AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Carl Zeiss Meditec AG compared to its peers.

Compare the P/E ratios
of Carl Zeiss Meditec AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Carl Zeiss Meditec AG with its peers.

Analyze the financial leverage
of Carl Zeiss Meditec AG compared to its main competitors.

Show all profitability ratios
for Carl Zeiss Meditec AG.

Provide ROE
for Carl Zeiss Meditec AG.

Provide ROA
for Carl Zeiss Meditec AG.

Provide ROIC
for Carl Zeiss Meditec AG.

Provide ROCE
for Carl Zeiss Meditec AG.

Provide Gross Margin
for Carl Zeiss Meditec AG.

Provide Operating Margin
for Carl Zeiss Meditec AG.

Provide Net Margin
for Carl Zeiss Meditec AG.

Provide FCF Margin
for Carl Zeiss Meditec AG.

Show all solvency ratios
for Carl Zeiss Meditec AG.

Provide D/E Ratio
for Carl Zeiss Meditec AG.

Provide D/A Ratio
for Carl Zeiss Meditec AG.

Provide Interest Coverage Ratio
for Carl Zeiss Meditec AG.

Provide Altman Z-Score Ratio
for Carl Zeiss Meditec AG.

Provide Quick Ratio
for Carl Zeiss Meditec AG.

Provide Current Ratio
for Carl Zeiss Meditec AG.

Provide Cash Ratio
for Carl Zeiss Meditec AG.

What is the historical Revenue growth
over the last 5 years for Carl Zeiss Meditec AG?

What is the historical Net Income growth
over the last 5 years for Carl Zeiss Meditec AG?

What is the current Free Cash Flow
of Carl Zeiss Meditec AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Carl Zeiss Meditec AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Carl Zeiss Meditec AG

Current Assets 1.8B
Cash & Short-Term Investments 33.8m
Receivables 1.2B
Other Current Assets 593.7m
Non-Current Assets 1.1B
Long-Term Investments 14m
PP&E 332.6m
Intangibles 684.5m
Other Non-Current Assets 110.5m
Current Liabilities 507.4m
Accounts Payable 186.7m
Accrued Liabilities 116.1m
Other Current Liabilities 204.7m
Non-Current Liabilities 318.5m
Long-Term Debt 217m
Other Non-Current Liabilities 101.5m
Efficiency

Earnings Waterfall
Carl Zeiss Meditec AG

Revenue
2.1B EUR
Cost of Revenue
-927.4m EUR
Gross Profit
1.1B EUR
Operating Expenses
-872.9m EUR
Operating Income
265.8m EUR
Other Expenses
-62.6m EUR
Net Income
203.2m EUR

Free Cash Flow Analysis
Carl Zeiss Meditec AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Carl Zeiss Meditec reported a slight revenue decline of 1.5% to EUR 1.487 billion for the first nine months of fiscal year 2023-24, impacted by adverse currency effects. EBIT fell by 34% to EUR 163 million, with a margin of 10.9%, largely due to reduced revenue and a weaker product mix. Despite tough market conditions, especially in North America, there are signs of stabilization in order intake. The company expects DORC to contribute EUR 100 million in revenue in the second half. Zeiss maintains a revenue target of EUR 2 billion and an adjusted EBIT range of EUR 225-275 million, focusing on strict cost control measures to mitigate economic challenges.

What is Earnings Call?
Fundamental Scores

AFX Profitability Score
Profitability Due Diligence

Carl Zeiss Meditec AG's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
55/100
Profitability
Score

Carl Zeiss Meditec AG's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

AFX Solvency Score
Solvency Due Diligence

Carl Zeiss Meditec AG's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
85/100
Solvency
Score

Carl Zeiss Meditec AG's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AFX Price Targets Summary
Carl Zeiss Meditec AG

Wall Street analysts forecast AFX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFX is 72.6 EUR with a low forecast of 54.54 EUR and a high forecast of 109.2 EUR.

Lowest
Price Target
54.54 EUR
2% Downside
Average
Price Target
72.6 EUR
31% Upside
Highest
Price Target
109.2 EUR
97% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AFX?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AFX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Carl Zeiss Meditec AG Logo
Carl Zeiss Meditec AG

Country

Germany

Industry

Health Care

Market Cap

5B EUR

Dividend Yield

1.98%

Description

Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 3,531 full-time employees. The company went IPO on 2000-03-20. The company offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The firm has various production sites in Europe, the United States and Asia.

Contact

THUERINGEN
Jena
Goeschwitzer Strasse 51-52
+4936412200.0
www.zeiss.de

IPO

2000-03-20

Employees

3 531

Officers

CEO & Chairman of Management Board
Dr. Markus Weber
CFO & Member of the Management Board
Mr. Justus Felix Wehmer
Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board
Dr. Christian Munster
Chief Operating Officer
Stefanie Spanagel
Director of Investor Relations
Mr. Sebastian Frericks
Chief Human Resources Officer
Eva-Maria Heine
Show More
Chief Medical Officer for Global Ophthalmic Devices
Mr. Steven C. Schallhorn M.D.
Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.
Mr. Andrew Chang
President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit
Dr. Euan S. Thomson Ph.D.
Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology
Mr. Magnus Reibenspiess
Show Less

See Also

Discover More
What is the Intrinsic Value of one AFX stock?

The intrinsic value of one AFX stock under the Base Case scenario is 100.24 EUR.

Is AFX stock undervalued or overvalued?

Compared to the current market price of 55.45 EUR, Carl Zeiss Meditec AG is Undervalued by 45%.

Back to Top